IF SARS-COV-2 VACCINATION IS BLAMED FOR PARSONAGE–TURNER SYNDROME, NEUROSURGICAL NEUROLYSIS IS NOT INDICATED We read with interest the article by Yeoh and Ramdzan describing the case of a 50-year-old man who was diagnosed with Parsonage–Turner syndrome (PTS) after vaccination with a booster dose of an mRNA-based SARS-CoV-2 vaccine.1 Symptoms started 5 days after vaccination, but the patient did not come to the hospital until 9 weeks after symptom onset. e patient benetted from neurosurgical neurolysis of C5, C6 and the upper trunk as well as low-level laser therapy. e study oers valuable information but has limitations that should be discussed.

Heart Diseases/epidemiology* ; Humans ; Parkinson Disease/drug therapy* ; Propolis